We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANDX
226
DELISTED
Andeavor Logistics LP
ANDX
| $78.9M | 0.1% |
1,760,793
-42,640
| -2% | -$2.08M |
|
227
BP
BP
$109B
| $78.7M | 0.1% |
2,089,577
+246,013
| +13% | +$9.27M |
|
|
NVRO
228
DELISTED
NEVRO CORP.
NVRO
| $78M | 0.1% |
900,043
-551
| -0.1% | -$44.5K |
|
229
CrossAmerica Partners
CAPL
$838M
| $77.8M | 0.1% |
3,783,442
+367,320
| +11% | +$8.49M |
|
230
Plains GP Holdings
PAGP
$5.16B
| $77.5M | 0.1% |
3,561,668
+185,975
| +6% | +$4.11M |
|
231
Black Hills Corp
BKH
$5.68B
| $76.3M | 0.1% |
1,405,505
+44,961
| +3% | +$2.41M |
|
232
Medtronic
MDT
$108B
| $75.2M | 0.09% |
937,472
-689,581
| -42% | -$56.9M |
|
233
Synopsys
SNPS
$74.5B
| $74.9M | 0.09% |
899,261
+16,313
| +2% | +$1.43M |
|
234
Microchip Technology
MCHP
$42.3B
| $74.7M | 0.09% |
1,635,346
-103,118
| -6% | -$4.75M |
|
235
Accenture
ACN
$94.3B
| $74.4M | 0.09% |
484,960
-18,056
| -4% | -$2.86M |
|
|
PSXP
236
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $74.3M | 0.09% |
1,555,631
-108,590
| -7% | -$5.58M |
|
|
RDS.A
237
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $73.8M | 0.09% |
1,155,812
-131,070
| -10% | -$8.63M |
|
238
Altria Group
MO
$122B
| $73.4M | 0.09% |
1,178,207
+393,167
| +50% | +$26M |
|
239
Crown Castle
CCI
$32.4B
| $73.1M | 0.09% |
666,558
+244,098
| +58% | +$26.5M |
|
|
ORIG
240
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $73.1M | 0.09% |
+2,895,461
| New | +$76M |
|
|
ESRX
241
DELISTED
Express Scripts Holding Company
ESRX
| $72.8M | 0.09% |
1,054,456
-1,589,295
| -60% | -$121M |
|
|
ABMD
242
DELISTED
Abiomed Inc
ABMD
| $72.6M | 0.09% |
249,507
-60,473
| -20% | -$15.3M |
|
243
Teva Pharmaceuticals
TEVA
$36.2B
| $72.3M | 0.09% |
4,229,508
+566,300
| +15% | +$11.1M |
|
244
Target
TGT
$63.7B
| $72.3M | 0.09% |
1,040,976
-165,954
| -14% | -$12.1M |
|
245
Repligen
RGEN
$7.39B
| $72M | 0.09% |
1,989,639
+310,164
| +18% | +$10.9M |
|
246
First Solar
FSLR
$22.1B
| $71.9M | 0.09% |
1,012,700
-254
| -0% | -$17.3K |
|
247
Nasdaq
NDAQ
$52.5B
| $70.8M | 0.09% |
2,464,248
-10,629
| -0.4% | -$287K |
|
248
Whirlpool
WHR
$2.44B
| $70.6M | 0.09% |
460,876
-1,261,256
| -73% | -$211M |
|
249
Quest Diagnostics
DGX
$25.6B
| $70.4M | 0.09% |
702,357
-5,415
| -0.8% | -$555K |
|
|
PF
250
DELISTED
Pinnacle Foods, Inc.
PF
| $69.9M | 0.09% |
1,292,924
-955,829
| -43% | -$55.1M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.